SCHEMBL18015299

SCHEMBL18015299

Cc1cn2ccc3cc(-c4ccccc4-c4cc(-c5ccccc5-c5ccc6c(ccn7cc(C)nc67)c5)cc(-c5ccccc5-c5ccc6c(ccn7cc(C)nc67)c5)c4)ccc3c2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
RAB9A P51151 5/20 0.41
NPC1 O15118 4/20 0.41
MAPT P10636 3/20 0.41
HPGD P15428 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
KDM4E B2RXH2 2/20 0.41
TP53 P04637 2/20 0.41
NFKB1 P19838 2/20 0.41
NFKB2 Q00653 2/20 0.41
RELA Q04206 2/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
KMT2A Q03164 1/20 0.41
ALDH1A3 P47895 6/20 0.36
ALDH1A2 O94788 3/20 0.36
PTAFR P25105 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
BLM P54132 1/20 0.35
TGFBR1 P36897 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19933706 0.94 ALDH1A3 (0.39) ALDH1A1RAB9ANPC1MAPTHPGD
SCHEMBL20068728 0.91 ALDH1A1 (0.38) ALDH1A1RAB9ANPC1MAPTHPGD
SCHEMBL21125818 0.89 ALDH1A1 (0.40) ALDH1A1RAB9ANPC1MAPTHPGD
SCHEMBL19933621 0.88 RAB9A (0.39) ALDH1A1RAB9ANPC1MAPTHPGD
SCHEMBL21398027 0.87 TGFBR1 (0.34) ALDH1A1RAB9ANPC1MAPTHPGD
SCHEMBL19933697 0.87 KMT2A (0.38) ALDH1A1RAB9ANPC1MAPTHPGD
SCHEMBL19933828 0.86 LPL (0.39) ALDH1A1RAB9ANPC1MAPTHPGD
SCHEMBL23956274 0.85 ALDH1A3 (0.39) ALDH1A1RAB9ANPC1MAPTHPGD
SCHEMBL23956355 0.85 ALDH1A1 (0.36) ALDH1A1RAB9ANPC1MAPTHPGD
SCHEMBL23956235 0.83 TGFBR1 (0.34) ALDH1A1RAB9ANPC1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 US disclosed
EP-3254317-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-31 EP disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
WO-2016124304-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC ALDH1A1 2742/4885RAB9A 2171/4885NPC1 4039/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 ALDH1A1 2597/4885RAB9A 1433/4885NPC1 2761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.